- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
Population: Elderly
Individuals aged 65 years and above
- Adults
- General population
- Elderly
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Community
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Adults
- Elderly
- Paediatric
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Blood sample
- Adults
- Elderly
- Paediatric
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults
- Elderly
- Fragile population
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Tixagevimab/Cilgavimab
- Elderly
- Fragile population
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
- Adults
- Elderly
- Fragile population
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab